Intravenous immunoglobulin induced pancytopenia while preventing development of gestational alloimmune liver disease: A case report
Gestational alloimmune liver disease is a rare complication associated with reactive maternal immunoglobulins resulting in neonatal liver pathology. The mainstay treatment for prevention in future pregnancies is intravenous immunoglobulins. Although relatively well tolerated, adverse reactions may o...
Saved in:
Main Authors: | Minhazur Sarker (Author), Chelsea DeBolt (Author), Noel Strong (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy of Intravenous Immunoglobulin/Exchange Transfusion Therapy on Gestational Alloimmune Liver Disease
by: Pai-Jui Yeh, et al.
Published: (2021) -
Drug-induced Liver Injury from Intravenous Immunoglobulin for Prevention of Recurrent Gestational Alloimmune Liver Disease: A Clinical Catch-22
by: Jessica A. Meyer, et al.
Published: (2024) -
Neonatal hemochromatosis attributed to gestational alloimmune liver disease treated with intravenous immunoglobulin and exchange transfusion therapy: an evidence-based case report
by: Adhi Teguh Perma Iskandar, et al.
Published: (2021) -
IVIG-Associated Maternal Pancytopenia during Treatment for Neonatal Alloimmune Thrombocytopenia
by: Alyssa Herrmann, et al.
Published: (2017) -
Successful pregnancy outcomes following intravenous immunoglobulin treatment in a woman with a previous fetal death in utero due to gestational alloimmune liver disease: A case report
by: Rebecca Moorhead, et al.
Published: (2022)